Factors Associated With the Non-Completion of Conventional Anti-Tuberculosis Treatment in Peru;Factores asociados al abandono de tratamiento antituberculoso convencional en Perú

Archivos de Bronconeumologia

Volumn 48, Issue 5, 2012, Pages 150-155

  Culqui, Dante R ^a,f   Munayco E , César V ^b   Grijalva, Carlos G ^c   Cayla, Joan A ^d   Horna Campos, Olivia ^a,d   Alva Ch , Kenedy ^e   Suarez O , Luis A ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b MINISTERIO DE SALUD   (Peru)

^c VANDERBILT UNIVERSITY   (United States)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^e UNIVERSIDAD CARLOS III DE MADRID   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Non compliance; Peru; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; CASE CONTROL STUDY; DRUG USE; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT INFORMATION; PERU; POVERTY; RISK ASSESSMENT; TUBERCULOSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; PERU; RETROSPECTIVE STUDIES; TUBERCULOSIS; YOUNG ADULT;

EID: 84860006770     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2011.12.008     Document Type: Article

References (28)

1. WHO. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2011. Ginebra: WHO; 2011.
2. Global tuberculosis control. WHO Report 2011 2011, World Health Organization, WHO, Ginebra.
3. Construyendo alianzas estratégicas para detener la tuberculosis: La experiencia peruana 2006, Ministerio de Salud, Dirección General de Salud de las Personas, Lima.
4. Ministerio de Salud. Norma Técnica de Salud para el Control de la Tuberculosis. Lima: Dirección General de Salud de las Personas; 2006.
5. Weis S.E., Slocum P.C., Blais F.X., King B., Nunn M., Matney G.B., et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994 Apr 28, 330:1179-1184.
6. Perú: Métodos de Medición de la Pobreza [Internet]. Lima:Instituto Nacional de Estadística e Informática; 1999 [consulta el 22 de junio del 2009]. Disponible en: http://www.inei.gob.pe/biblioineipub/bancopub/Est/Lib0329/indice.HTM.
7. Thomas R, Daly MPJ. Forewarned is forearmed - Randomised evaluation of a preparatory information film for cancer patients. European Journal of Cancer. August 2000.
8. Thomas R., Thorton H., Mackay J. Patient information materials in oncology: are they needed and do they work?. Clin Oncol (R Coll Radiol) 1999, 11:225-231.
9. Olson D.H., Wilson M. Family satisfaction. Family inventories. Family Social Science 1982, University of Minnesota, St. Paul, Minnesota. D.H. Olson, H. McCubbin, H. Barnes, A. Larsen, M. Muxen, W. Wilson (Eds.).
10. Braga M., Mello D.A., Morais A.P.P., Da Silva W.C. Estudo de casos sobre abandono do tratamento da tuberculose: avaliação do atendemento, percepção e conhecimentos sobre a doença na perspectiva dos clientes (Fortaleza, Cearám Brasil). Cad Saúde Pública 2001, 17:877-885.
11. Burman W.J., Cohn D.L., Rietmeijer C.A., Judson F.N., Sbarbaro J.A., Reves R.R. Short-term incarceration for the treatment of non compliance with tuberculosis treatment. Chest 1997, 112:57-62.
12. Jha U.M., Satyanarayana S., Dewan P.K., Chadha S., Wares F., Sahu S., Gupta D., Chauhan L.S. Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006. PLoS One 2010, 5:e8873.
13. Horna-Campos O.J., Consiglio E., Sánchez-Pérez H.J., Navarro A., Caylà J.A., Martín-Mateo M. Pulmonary tuberculosis infection among workers in the informal public transport sector in Lima, Peru. Occup Environ Med 2011, 68:163-165. Epub 2010 Nov 23.
14. Galván F., Santiuste C. Factores relacionados con el cumplimiento de la quimioprofilaxis contra la tuberculosis. Med Clín (Barc) 1998, 111:655-657.
15. Troiano S., Forciniti S., Rodríguez P. Abandono de tratamiento de pacientes con tuberculosis. Rev Arg Tórax 1999, 60:58-63.
16. Al-Hajjaj M.S., Al-Khatim I.M. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval system: a call for implementation of directly observed therapy in Saudi Arabia. Int J Tuberc Lung Dis 2000, 4:345-349.
17. Pozsik C.J. Compliance with tuberculosis therapy. Med Clin North Am 1993, 77:1289-1301.
18. Jimenez G.D., López P.D., Medrano M.J., Valle M.J. Factores asociados al abandono de pacientes bacillíferos al programa de control de tuberculosis, Managua, Nicaragua, 1998-1999 1992, Centro de Investigaciones y Estudios de la Salud (CIES-UNAN), Managua, 1-42.
19. Bam T.S., Gunneberg C., Chamaroonsawasdi K., Bam D.S., Aalberg O., Kasland O., et al. Factors affecting patient adherence to DOTS in urban Kathmandu Nepal. Int J Tuberc Lung Dis 2006, 10:270-276.
20. Caylà J.A., Rodrigo T., Ruiz-Manzano J., Caminero J.A., Vidal R., García J.M., Blanquer R., Casals M. Working Gro up on Completion of Tuberculosis Treatment in Spain (Study ECUTTE): Tuberculosis treatment adherence and fatality in Spain. Respir Res 2009, 10:121.
21. Vijay S., Kumar P., Chauhan L.S., Vollepore B.H., Kizhakkethil U.P., et al. Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India. PLoS ONE 2010, 5:e10043. 10.1371/journal.pone.0010043.
22. ¿Qué es la estrategia DOTS/TAES? Guía para comprender la estrategia de lucha antituberculosa recomendada por la OMS y conocida como estrategia DOTS/TAES. Ginebra: OMS; 1999.
23. Jaiswal A., Singh V., Ogden J.A., Porter J.D.H., Sharma P.P., et al. Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India. Trop Med Int Health 2003, 8:625-633.
24. George L.J. Compliance with medication and directly observed therapy in the treatment of TB in Lesotho [PhD dissertation] 2003, Faculty of the School of Social Work, University of Pennsylvania, Filadelfia (PA), 300 p.
25. Homedes N., Ugalde A. ¿Qué sabemos del cumplimiento de los tratamientos médicos en el tercer mundo?. Bol Of Sanit Panam 1994, 116:491-517.
26. Soza Pineda N.I., Pereira S.M., Barreto M.L. Abandono del tratamiento de la tuberculosis en Nicaragua: resultados de un estudio comparativo. Rev Panam Salud Publica 2005, 17:271-278.
27. Peltzer K., et al. Factors at first diagnosis of tuberculosis associated with compliance with the directly observed therapy (DOT) in the Limpopo Province, South Africa 2002. Curationis 2002, 25:55-67.
28. Bam T.S.a., Chand K.B.b., Shrestha S.D.c. Factors Responsible for Non-compliance among Tuberculosis Patients in Kailali District. Nepal Journal of Nepal Health Research Council 2005, 3.